Melanie Sena

FDA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

Tigermed acquires Frontage Laboratories for $50.25 million.

AstraZeneca's Epanova is the first FDA-approved prescription omega-3 in free fatty acid form.

Bayer will acquire the consumer care business of Merck & Co., and enter a co-commercialization agreement in the field of sGC modulators.

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.

Eli Lilly has developed the Lilly Medical Student Intern Program for future physicians.

Novartis' eBook features images of meningococcal disease survivors from around the world.

Laser Diffraction Software Supports Analytical QbD

Shire acquires Fibrotech for $75 million.

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

UPM will commercially manufacture two ANDA products for Amerigen Pharmaceuticals.

Lilly's Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.

SI Group agrees to purchase certain Albemarle assets and products.

A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.

Ian Read, chairman and CEO of Pfizer, is elected chairman of the PhRMA.

CBER will move to the FDA White Oak campus in Silver Spring, Maryland.

Aesica's consortium project receives grant to investigate an industrial biotechnology process to improve the manufacturing of an API.

Fette Compacting America appoints Sean Scully as its new president.

The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.

uniQure appoints a new COO and vice president, Medical affairs.

ChemCon passes its fourth FDA inspection in the 17-year history of the company.

Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.

FDA approves Oralair, the first sublingual allergen extract for the treatment of pollen allergies.

SyncOperations Software Helps Increase Workflow

Arc View Handheld Mobile Sensor Enhances Measurements

CLARiSUITE Software Improves Accessibility and Productivity

Multirobot Offline Programming Software Allows 3-D Simulation

Carolina Medical Products changes its name to CMP Pharma to reflect current business trends.

The I'm In campaign is designed to increase participation by diverse patient populations for clinical trials.